Kidney disease

Patients with severe renal impairment have difficulty obtaining adequate amounts of protein, leading to lower immune levels and aggravation of the disease. In the case of dialysis treatment, maintaining a normal metabolic state with nutrition is even more important for the therapeutic effect.

Introduction


The current global prevalence of chronic kidney disease is 10.1%-13.3%, surpassing the prevalence of diabetes, chronic obstructive pulmonary disease, and depression, and chronic kidney disease is expected to become the fifth leading cause of death worldwide by 2040. Because damage to kidney function such as renal failure or tubular necrosis is irreversible and has a long treatment period, chronic kidney disease and end-stage renal disease are important research areas for chronic disease management and clinical nutritional interventions to help related patients achieve better treatment outcomes and quality of life during the course of the disease.

Read More

Challenges and nutritional requirements of kidney disease


During the development of kidney disease, the body's needs and utilization of different nutrients are always changing, such as at different stages of the disease, whether the patient is already on or about to receive dialysis treatment, etc. Inappropriate nutritional intake often increases the burden on the kidneys and worsens the disease. This means that patients need to constantly adjust their diet and nutritional needs as their disease continues to change, which is actually difficult to do on an individual basis.


s1p25

s2p25

s3p25


Nutritional Support for Kidney Disease Patients


The 2020 U.S. Kidney Disease and Dialysis Patient Survival Quality Guidelines (KDOQI) updated the Clinical Practice Guideline: Nutrition for Patients with Chronic Kidney Disease to provide guidance in six key areas.

  • Medical Nutrition Therapy (MNT)

  • Dietary protein and energy intake

  • Nutritional supplementation

  • Micronutrients

  • Electrolytes



Advantages of kidney disease-specific formula


Through the rational design of protein sources and intake, the use of a variety of lipids as the main source of energy intake, strict control of sodium, potassium, phosphorus and other trace elements intake, systematically reduce the metabolic burden on the kidneys on the basis of ensuring that patients receive an adequate supply of nutrients, providing the basis for better treatment results. Kidney disease-specific formulas can provide

  • Precise intakes of sodium, potassium, phosphorus and calcium

  • Protein with high digestibility and absorption

  • Essential polyunsaturated fatty acids (PUFA) for the body

  • Monounsaturated fatty acids (SUFA)



Rich lipids with immune components


Lipid components are effective in providing energy to the body while also providing assistance to the body in controlling inflammation. Numerous studies have shown that n-3 fatty acids with a reasonable ratio of n-3:n-6 fatty acids have significant immune functions, helping to improve cellular and humoral immune indicators and reducing the risk of kidney inflammation and other inflammatory conditions caused by infection.



Bone related nutrients


Reduced calcium absorption due to kidney injury and reduced calcium deposition due to reduced activity result in significantly lower bone mineral density in patients with kidney disease than in normals, increasing the risk of osteoporosis or fracture. One study showed that the overall incidence of hip fracture in patients with chronic renal failure was 17.4 times higher than in the healthier population, with 58.5% having reduced bone mass and a mortality rate of 64% one year after a concurrent hip fracture. Considering that excessive calcium intake also increases the therapeutic risk of patients with blood calcium disorders, the occurrence of skeletal-related complications can be reduced by controlling calcium intake and improving calcium absorption and deposition by the body through vitamins.



Conclusion


Due to the long duration of the disease, the irreversibility of the damage and the strong correlation with the body's metabolism, the nutritional intake of patients with kidney disease needs to be extraordinarily precise. On the basis of precise nutrition, providing a variety of formulas suitable for different disease stages and treatments can guide the body to maintain a long-term benign metabolic state and reduce the physical and mental burden of patients.



References

【1】中国慢性肾脏病营养治疗临床实践指南(2021版)[J].中华医学杂志,2021,101(08):539-559.

【2】Fiaccadori Enrico,Sabatino Alice,Barazzoni Rocco,Carrero Juan Jesus,Cupisti Adamasco,De Waele Elisabeth,Jonckheer Joop,Singer Pierre,Cuerda Cristina. ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease[J]. Clinical Nutrition,2021,40(4).

【3】N. Cano,E. Fiaccadori,P. Tesinsky,G. Toigo,W. Druml,M. Kuhlmann,H. Mann,W.H. Hörl. ESPEN Guidelines on Enteral Nutrition: Adult Renal Failure[J]. Clinical Nutrition,2006,25(2).


  • Client Support
    Provide up-to-date academic information, national compliance business policies, and support medical professionals and healthcare service providers in achieving the ideal application of practice.
  • Nutrition for special medical purposes
    Click here to check the suitable product.
  • News
    Find the latest announcements and updates from Kwins Health.
  • You may still be following
    Consult us
    Contact our team of experts for guidance on product use and ingredients, as well as services such as sample acquisition. Or help you contact your local Kwins Health team to address your specific questions.
  • Tel
    0523-80108333点击号码即可拨出
  • E-mail
    huqm219@163.com
  • Address
    No.363 Taizhou Avenue, China Medical City, Taizhou City, Jiangsu Province
  • Follow Us

    Copyright Kwins Health Pharmaceutical Jiangsu Co.